No abstract

The purpose of this work is to evaluate the roles of lecithin and bile salts in a new generation of fasted simulated small intestinal fluid (FaSSIF-II), thus enhancing the closer mimic of simulated fluids to the real human intestinal fluids (HIF) in drug discovery and drug product development. To assess the effects of lecithin in FaSSIF-II, solubility studies were conducted at 37 °C using four media including first generation simulated intestinal fluid (FaSSIF-I), FaSSIF-II, phosphate pH 6.5 buffer, and HIF. A total of 24 model compounds representing a wide range of biopharmaceutic properties were included. The drug solubility values measured in the FaSSIF-II were compared with those in FaSSIF-I, pH 6.5 buffer and HIF. To assess the effects of bile acids, solubility was measured for 4 compounds in the FaSSIF-I containing five different bile acids of various concentrations. The lecithin concentration in the FaSSIF-II is lowered from 0.75 mM to 0.2 mM. The results suggested that the FaSSIF-II is a better medium to reflect HIF, compared with pH 6.5 phosphate buffer and FaSSIF-I. Solubility of neutral compounds including atovaquone, carbamazepine, cyclosporine, danazol, diethylstilbestrol, felodipine, griseofulvin and probucol in FaSSIF-II showed improvement in predicting the in vivo solubility. The relative standard deviation (SD) of solubility measurement in FaSSIF-II is comparable with FaSSIF-I. For the acidic and basic tested compounds, the FaSSIF-II performs similarly to the FaSSIF-I. Experimental results showed that the level of bile salts typically is less than 5 mM under fasted state. Among the five studied bile acids, the conjugation (glycine or taurine) has no impact on the drug solubilization, while there may be a minimal effect of the degree of hydroxylation of the steroid ring system on solubilization. The lecithin concentration of 0.2 mM in FaSSIF-II has been demonstrated to closely represent HIF, for both neutral and ionizable compounds. In the composition of simulated intestinal fluids, the structure of bile acids has minimal effect, providing the flexibility of choosing one bile salt to represent complex in vivo bile acids.

The role of proteins in biomineralization has been examined in this work by studying the effect of ovalbumin on the stabilization of metastable CaCO(3) phases. In the absence of ovalbumin, the mixing of Na(2)CO(3) with CaCl(2) in an aqueous solution led to the formation of metastable phases that swiftly transformed into stable calcite crystals within 4 h under the experimental conditions. However, ovalbumin was found to favor the formation and stabilization of spherical vaterites, and the effect was concentration dependent. In the presence of 2 g/L ovalbumin, for example, vaterite microspheres with diameters ranging from 0.9 to 3.0 mum, composed of much smaller nanosized particles, were produced and stabilized even after 24 h following the initial mixing. In addition, the influence of ovalbumin on the CaCO(3) mineralization process from the very beginning was carefully examined. Both amorphous calcium carbonate (ACC) and vaterite were favored with ovalbumin present, but the ACC phase formed predominantly at the initial stage of mixing followed by the vaterite formation. Vaterite could then be embedded further in the mineralization process and become stabilized many hours afterward. The stabilizing effect of ovalbumin could arise from the strong binding between carboxylate groups of ovalbumin and the calcium ions on the CaCO(3) surface, preventing the metastable CaCO(3) from transformation via dissolution-recrystallization processes. The strong ovalbumin adsorption on vaterite microspheres was revealed from transmission electron microscopy imaging and thermogravimetric analysis, thereby providing useful evidence to support the proposed stabilizing mechanism.

No abstract

No abstract

No abstract

No abstract

No abstract